Background and Purpose-Despite rapid advancements in intracranial aneurysm management, there is no evidence as of yet that this has translated into improvement in overall prognosis. 
M anagement of intracranial aneurysms has greatly evolved over the past 2 decades. New evidence has prompted changes in multiple aspects of patient care including diagnosis, imaging surveillance, and indications and strategies for aneurysm obliteration. For patients presenting with aneurysmal subarachnoid hemorrhage (SAH), updated guidelines for the prevention of aneurysmal rerupture, management of delayed cerebral ischemia, hydrocephalus, and medical complications of SAH have been developed. 1 Analyses of nationwide trends using Nationwide Inpatient Sample (NIS) data have demonstrated a marked increase in the usage of endovascular therapy for both ruptured and unruptured aneurysms. [2] [3] [4] [5] [6] [7] The usage of endovascular therapy has spread from large academic hospitals to smaller hospitals across all geographic regions 5 and has become the procedure of choice in older patients. 8, 9 Endovascular therapy has resulted in improved morbidity and mortality, fewer adverse events, and shorter mean length of hospital stay than surgical clipping. [2] [3] [4] 8, 10 A key limitation of NIS studies is that the NIS database does not record important predictors of outcome including neurological status at presentation and the amount of subarachnoid blood. As such, it is unclear whether improved outcomes are because of increased usage of endovascular therapy in patients with less severe presentations. 9 In addition, the impact of evolving aneurysm management strategies on outcomes for patients with different clinical risk factors has yet to be investigated.
Methods

Study Design
This study was conducted in accordance with institutional guidelines and with the approval of the institutional review board. We retrospectively reviewed medical records and imaging studies for patients who received treatment for intracranial aneurysms at Massachusetts General Hospital from 1998 to 2003 and 2007 to 2013, representing aneurysm management before and several years after the publication of the International Subarachnoid Aneurysm Trial (ISAT), allowing sufficient time for ISAT findings to be adapted into clinical practice.
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Our primary outcome was low or moderate disability at ≥6 months post treatment, defined as a Glasgow Outcome Scale scores of 4 (not requiring assistance in everyday life) or 5 (minor neurological and psychological deficits). A per-aneurysm analysis was used to allow us to interrogate and control for aneurysm-specific factors such as size and location. Cases with <6 months of clinical follow-up were excluded from the study. In univariable analysis, patients were classified as young (≤50 years) or old (>50 years) to permit subgroup analysis.
Statistical analysis was performed using R version 3.1.1 (http:// www.r-project.org). In univariable analysis, variables were compared between groups by the Pearson χ 2 test. Statistical significance was defined as P<0.025 and P<0.0125 for unruptured and ruptured aneurysms, respectively, using the Bonferroni correction. Changes in outcome for surgical, endovascular, and overall treatment of unruptured and ruptured aneurysms were examined using multivariable logistic regression models, accounting for patient age, aneurysm size, location (anterior or posterior circulation), neurological status at admission (Hunt and Hess grade), and amount of subarachnoid blood (Fisher grade), which are recognized predictors of outcome. 12, 13 Aneurysm size was defined as the largest dimension of the aneurysm (dome, length, or height). The original Fisher scale was used in this study to permit inclusion of aneurysms treated before the publication of the modified Fisher scale because a majority of old imaging studies are not presently available. Although less discriminative than the modified Fisher scale, the original Fisher scale correlates with the development of symptomatic vasospasm and has high interobserver agreement.
14 All variables were included in the models without the use of a stepwise or other formal variable selection process. As the incidence of our outcome of interest (low or moderate disability) was high (>10%), relative risk was approximated from the logistic regression odds ratio as described by Zhang and Yu. 
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Results
Patient Characteristics
Treatment Characteristics
There was increased usage of endovascular therapy for the treatment of both unruptured (P<0.0001) and ruptured (P=0.000371) aneurysms in 2007 to 2013 when compared with 1998 to 2003 ( Table 2) . For unruptured aneurysms, there was increased usage of endovascular therapy for both younger (≤50 years) (P<0.0001) and older (>50 years; P<0.0001) patients and for both anterior (P<0.0001) and posterior (P<0.0001) circulation aneurysms. For ruptured aneurysms, there was increased usage of endovascular therapy for older patients (P<0.0001), good grade aneurysms (Hunt and Hess, 1-3; P<0.0001; Fisher 1-2; P=0.0018), and anterior circulation aneurysms (P<0.0001).
Outcomes
There was a significant increase in proportion of cases with low or moderate disability (Glasgow Outcome Scale scores of 4 or 5) at ≥6 months post treatment for surgical, endovascular, and overall treatment of both unruptured and ruptured aneurysms after adjusting for age, aneurysm size, location (anterior versus posterior circulation), neurological status at admission (Hunt and Hess grade), and amount of subarachnoid blood (Fisher grade; Tables 3 and 4 ). Outcomes associated with individual risk factors (age, location, Hunt and Hess grade, and Fisher grade) are reported in Table 5 . For unruptured aneurysms, there were significant improvements in overall outcome for older patients (P<0.0001) and aneurysms in the posterior circulation (P=0.00857; Table 5 ). For ruptured aneurysms, there were significant improvements in overall outcome for both younger (P=0.000888) and older (P<0.0001) patients, patients presenting with both good (P<0.0001) and poor Hunt and Hess grade (P=0.000375), patients with poor Fisher grade (P<0.0001), and both anterior (P<0.0001) and posterior (P<0.0001) circulation aneurysms (Table 5 ).
Discussion
We report significant improvements in clinical outcome for surgical, endovascular, and overall treatment of unruptured and ruptured aneurysms from 1998 to 2003 to 2007 to 2013 (Tables 3-5) . These findings are highly encouraging as SAH has traditionally been associated with dismal prognosis. [16] [17] [18] In our 2007 to 2013 cohort, the proportion of cases with low or moderate disability at ≥6 months post SAH was 75.6% for surgical clipping and 76.6% for endovascular therapy. Improved outcomes were associated with a general increase in usage of endovascular therapy (Table 2 ). However, conclusions on causation cannot be drawn as this is not a randomized controlled study.
Relatively more unruptured aneurysms in older patients (>50 years) were treated in 2007 to 2013 versus 1998 to 2003 
Stroke
March 2016 (Table 1) , which is consistent with recent analyses of NIS data documenting a substantial increase in annual treatment of unruptured aneurysms, whereas treatment of ruptured aneurysms remained stable. 5 This almost certainly reflects increased usage of endovascular therapy as a less invasive therapeutic option for older patients who are poor candidates for surgery (Table 2 ). In our cohort, increased usage of endovascular therapy in older patients was associated with improved outcomes for both unruptured (92.5% versus 97.7%; P<0.0001) and ruptured (46.3% versus 72.7%; P<0.0001) aneurysms (Table 5 ). This broadly supports the prevailing preference for endovascular therapy and increased elective treatment of unruptured aneurysms in older patients despite concerns for thromboembolic complications caused by atheromatous degeneration and tortuosity of intracranial vessels. 19, 20 It is possible that the thromboembolic complication risk has been reduced with the development of more advanced devices and greater provider experience with endovascular techniques.
Poor neurological status at presentation is a significant predictor of poor outcome, with reported mortality rates of 12% to 59% in patients of any age. [19] [20] [21] Table 5 ), suggesting that progress in neurocritical care and aggressive management of complications such as hydrocephalus and, in particular, cerebral vasospasm and delayed cerebral ischemia are likely to be key contributors to improved functional outcomes. 1 This work complements NIS studies reporting increased usage of endovascular therapy across demographic groups, including sex, race, income, and hospitals although surgical clipping is still being offered to a substantial number of patients, especially those who are younger (Tables 3 and 4) . 5, 9 Surgical clipping may be preferable for younger patients because of better durability and lower risk of rerupture, 6, 22 particularly in high-volume academic centers with low complication rates. In contrast to previous studies of NIS data, [2] [3] [4] 8, 10 we did not find any statistically significant differences in outcome for surgical clipping versus endovascular therapy in the post-ISAT period. This raises the possibility that NIS findings may be because of increased usage of endovascular therapy in patients with less severe presentations and higher complication rates from surgical clipping in smaller neurovascular centers.
Our findings reflect the experience of a single, high-volume neurovascular center with a unique patient referral pattern, which certainly limits the generalizability of our data. Nevertheless, this is encouraging evidence that advancements in aneurysm management strategies are being translated into improved outcomes. For neurosurgeons providing counseling to patients and families, it is important to know that prognosis is improving. This study involved a retrospective analysis of previously recorded outcomes (at ≥6 months post treatment) from 1998 to 2003. For consistency, cases from 2007 to 2013 with <6 months of clinical follow-up were excluded as well. However, this is unlikely to have significantly affected our findings as the proportion of cases which were lost to followup from both time periods is low. In addition, we were able to capture neurological recovery, which has been documented at and beyond 6 months post treatment. 23 As this is a retrospective cohort study, the possibility of residual confounding cannot be excluded. For example, we cannot describe how patient referral patterns have changed. Improved outcomes are likely because of a combination of factors including increased usage of endovascular therapy, improved ICU care, and better selection of patients for surgery versus endovascular therapy. Outcomes are reported as number of patients with low or moderate disability (Glasgow Outcome Scale score of 4 or 5)/total number of patients in each risk category (proportion of patients with low or moderate disability). Statistical significance was assessed at P<0.025 and P<0.0125 for unruptured and ruptured aneurysms, respectively, using the Bonferroni correction. 
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